⌘K

Login Start Free

Home/Filings/4/0001246360-17-002026

4//SEC Filing

NxStage Medical, Inc. 4

Accession 0001246360-17-002026

CIK 0001333170operating

View on SEC.gov Company Profile

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:07 PM ET

Size

5.2 KB

Accession

0001246360-17-002026

Insider Transaction Report

Form 4

Period: 2017-05-25

NxStage Medical, Inc.NXTM

Director

Transactions

Award
Stock Option (Right to Buy)
2017-05-25+15,643→ 15,643 total
Exercise: $22.78From: 2017-06-25Exp: 2024-05-24→ Common Stock (15,643 underlying)

Footnotes (1)

[F1]The stock option becomes exercisable in 12 equal monthly installments beginning June 25, 2017.

Documents

1 file

4
form.xmlPrimary
PRIMARY DOCUMENT

Issuer

NxStage Medical, Inc.

CIK 0001333170

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001333170

Filing Metadata

Form type: 4
Filed: May 25, 8:00 PM ET
Accepted: May 26, 4:07 PM ET
Size: 5.2 KB

View on SEC.gov